Myelofibrosis patients in Belgium: disease characteristics.

Timothy Devos, P. Zachee, D. Bron, L. Noens, Jan Van Droogenbroeck, P. Mineur, Yves Beguin, Zwi Berneman, Fs Benghiat, A. Kentos, C. Chatelain, H. Demuynck, J. Lemmens, Kg Eygen, Koen Theunissen, Fabienne Trullemans, P. Pierre, W. Pluymers, Laurent Knoops

    Onderzoeksoutput: Articlepeer review

    6 Citaten (Scopus)

    Samenvatting

    Objective: To date, only a small number of epidemiological studies on myelofibrosis have been performed. The current study aimed to characterize the myelofibrosis patient population in Belgium according to pre-defined disease parameters (diagnosis, risk categories, hemoglobin 50.000/µl and 201 (80%) had platelet count >100.000/µl. Of 250 patients, 85 (34%) had a myeloblast count >1%. Six (2%) patients had undergone a splenectomy. Thirteen (5* 2%) patients had undergone radiotherapy for splenomegaly. Conclusions: The results of this survey provide insight into the characteristics of the Belgian myelofibrosis population. They also suggest that a large proportion of these patients could stand to benefit from the therapies currently under development.
    Originele taal-2English
    Pagina's (van-tot)105-111
    TijdschriftActa Clin Belg
    Volume70
    Nummer van het tijdschrift2
    Vroegere onlinedatum6 nov 2014
    StatusPublished - apr 2015

    Vingerafdruk

    Duik in de onderzoeksthema's van 'Myelofibrosis patients in Belgium: disease characteristics.'. Samen vormen ze een unieke vingerafdruk.

    Citeer dit